Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
727
datasets available to search
ShareScore release 0.9.0
Dataset results
727 results for “MP”
German MP-18 (ww1)
[ Info ] I did not do the modelling for this item. I've updated the UV's and Textured it. If you want to check out my work: ✚ Youtube: https://tinyurl.com/SubscribeToJanovich Source: Objaverse 1.0 / Sketchfab
Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C
ClinicalTrials.gov study NCT01753557. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients
ClinicalTrials.gov study NCT00739648. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02081599. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01072331. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients
ClinicalTrials.gov study NCT00677365. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency
ClinicalTrials.gov study NCT02870309. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults
ClinicalTrials.gov study NCT00295061. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01026194. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.
ClinicalTrials.gov study NCT00405756. IPD Sharing: Not stated. Countries: 22. Publications: 3.
Safety and PK Study of MP-424 to Treat Chronic Hepatitis C
ClinicalTrials.gov study NCT00591214. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients
ClinicalTrials.gov study NCT01468584. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients
ClinicalTrials.gov study NCT01466192. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency
ClinicalTrials.gov study NCT00301366. IPD Sharing: Not stated. Countries: 2. Publications: 3.
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
ClinicalTrials.gov study NCT05584189. IPD Sharing: NO. Countries: 1. Publications: 3.
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
ClinicalTrials.gov study NCT00780910. IPD Sharing: Not stated. Countries: 1. Publications: 1.
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
ClinicalTrials.gov study NCT05584176. IPD Sharing: NO. Countries: 1. Publications: 3.
Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01301833. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C
ClinicalTrials.gov study NCT00780416. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00971243. IPD Sharing: Not stated. Countries: 7. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.